雜志介紹

Cellular Reprogramming雜志介紹

《Cellular Reprogramming》是一本以English為主的未開放獲取國際優秀期刊，中文名稱細胞重編程，本刊主要出版、報道醫學-BIOTECHNOLOGY & APPLIED MICROBIOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為1.2，最新CiteScore 指數為2.5。

本刊近期中國學者發表的論文主要有：

• Improves the In Vitro Developmental Competence and Reprogramming Efficiency of Cloned Bovine Embryos by Additional Complimentary Cytoplasm.

  Author: Xu L¹, Mesalam A^1,2, Lee KL¹, Song SH¹, Khan I¹, Chowdhury MMR^1,3, Lv W⁴, Kong IK^1,5.

• Rosuvastatin Regulates Odontoblast Differentiation by Suppressing NF-κB Activation in an Inflammatory Environment.

  Author: Feng X¹, Wang C¹, Gu Z², Ni J³, Huang D¹, Feng G¹, Lian M¹, Lu Q⁴, Song Y¹.

• The Role of 5-aza-2'-Deoxycytidine on Methylation Status of Xist Gene in Different Genders of Buffalo (Bubalus bubalis) Bone Marrow Mesenchymal Stem Cells.

  Author: Zhao X¹, Ruan Z¹, Qin X¹, Feng Y¹, Yu Q¹, Xu J¹, Deng Y¹, Shen P¹, Shi D¹, Lu F¹.

• Rosuvastatin Alleviates Ischemia/Reperfusion Injury in Cardiomyocytes by Downregulating Hsa-miR-24-3p to Target Upregulated Uncoupling Protein 2.

  Author: Wei W¹, Peng J¹, Shen T².

英文介紹

Cellular Reprogramming雜志英文介紹

Cellular Reprogramming is the premier journal dedicated to providing new insights on the etiology, development, and potential treatment of various diseases through reprogramming cellular mechanisms. The Journal delivers information on cutting-edge techniques and the latest high-quality research and discoveries that are transforming biomedical research.

Cellular Reprogramming coverage includes:

Somatic cell nuclear transfer and reprogramming in early embryos

Embryonic stem cells

Nuclear transfer stem cells (stem cells derived from nuclear transfer embryos)

Generation of induced pluripotent stem (iPS) cells and/or potential for cell-based therapies

Epigenetics

Adult stem cells and pluripotency.